MAPT and early-onset autosomal dominant Alzheimer disease: TMAO is associated with Alzheimer’s disease through various pathophysiological pathways, including the aggregation of amyloid-beta peptide and tau protein, which are key in the development of Alzheimer’s disease pathology.